RUVBL1 and neoplasm: Remarkably, the combination of sgRUVBL1 and JQ1 dramatically inhibited the in vivo EwS tumor progression (red; Figure 6A,B), providing a proof‐of‐concept efficacy of synergistic targeting RUVBL1 and MYC in EwS.